Literature DB >> 12413995

Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist.

Shaun C Williams1, William E Gibbons, Suheil J Muasher, Sergio Oehninger.   

Abstract

OBJECTIVE: To compare the results of a minimal-stimulation protocol with those of a standard protocol used for IVF.
DESIGN: Retrospective, controlled study.
SETTING: University center. PATIENT(S): Fifty-five patients undergoing IVF using a minimal-stimulation protocol with or without adjuvant therapy with a GnRH antagonist. A control group consisted of age- and diagnosis-matched patients undergoing a standard long GnRH agonist (GnRH-a)-gonadotropin stimulation during the same time period. INTERVENTION(S): Clomiphene citrate and gonadotropins, with or without the GnRH antagonist ganirelix. MAIN OUTCOME MEASURE(S): Oocytes recovered and pregnancy rates. RESULT(S): The number of oocytes retrieved was significantly lower for the minimal-stimulation regimen compared with the case of the long GnRH-a protocol (4.8 +/- 2.6 vs. 16.2 +/- 7.5, respectively). The clinical pregnancy rate per transfer, however, was not significantly different between the two regimens (37% vs. 41%, minimal stimulation vs. long GnRH-a protocol, respectively). The addition of ganirelix resulted in at least the same pregnancy outcome as compared with the case of cycles without the antagonist. CONCLUSION(S): Minimal stimulation using clomiphene citrate followed by gonadotropin for IVF results in pregnancy rates equal to the standard long GnRH-a-gonadotropin protocol. The addition of ganirelix resulted in at least similar results with the advantage of eliminating the occurrence of a premature endogenous LH surge.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413995     DOI: 10.1016/s0015-0282(02)03374-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

1.  Comparison of clinical outcome and costs with CC + gonadotropins and gnrha + gonadotropins during Ivf/ICSI cycles.

Authors:  Peter Kovacs; Szabolcs Matyas; l Artur Bernard; Steven G Kaali
Journal:  J Assist Reprod Genet       Date:  2004-06       Impact factor: 3.412

Review 2.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

3.  The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome.

Authors:  Atsushi Yanaihara; Takeshi Yorimitsu; Hiroshi Motoyama; Motohiro Ohara; Toshihiro Kawamura
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

4.  IVF in Developing Economies and Low Resource Countries: An Overview.

Authors:  G N Allahbadia
Journal:  J Obstet Gynaecol India       Date:  2013-10

5.  IVF Lite: Is this the Future of Assisted Reproduction?

Authors:  G N Allahbadia
Journal:  J Obstet Gynaecol India       Date:  2013-03

Review 6.  Comparison of different stimulation protocols used in in vitro fertilization: a review.

Authors:  Deekshya Shrestha; Xiaolin La; Huai L Feng
Journal:  Ann Transl Med       Date:  2015-06

7.  Affordable ART for developing countries: a cost benefit comparison of low dose stimulation versus high dose GnRH antagonist protocol.

Authors:  M Noorashikin; F B Ong; M H Omar; M R Zainul-Rashid; A Z Murad; A Shamsir; M A Norsina; A Nurshaireen; N S M N Sharifah-Teh; A H Fazilah
Journal:  J Assist Reprod Genet       Date:  2008-07-25       Impact factor: 3.412

8.  Mild stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist and its influence on serum estradiol level and pregnancy rate.

Authors:  Atsushi Yanaihara; Takeshi Yorimitsu; Hiroshi Motoyama; Motohiro Ohara; Toshihiro Kawamura
Journal:  Reprod Med Biol       Date:  2008-04-17

Review 9.  Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.

Authors:  Alberto Revelli; Simona Casano; Francesca Salvagno; Luisa Delle Piane
Journal:  Reprod Biol Endocrinol       Date:  2011-02-16       Impact factor: 5.211

10.  Using a mild stimulation protocol combined with clomiphene citrate and recombinant follicle-stimulating hormone to determine the optimal number of oocytes needed to achieve pregnancy and reduce the concerns of patients.

Authors:  Rikikazu Sugiyama; Koji Nakagawa; Yayoi Nishi; Yuko Ojiro; Hiroyasu Juen; Rie Sugiyama; Yasushi Kuribayashi
Journal:  Reprod Med Biol       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.